Profile | GDS4284 / 241795_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 310.96 | 57 |
GSM687648 | Patient 402 control | 256.77 | 53 |
GSM687653 | Patient 403 control | 206.199 | 50 |
GSM687658 | Patient 404 control | 286.99 | 55 |
GSM687663 | Patient 411 control | 293.499 | 54 |
GSM687668 | Patient 422 control | 165.142 | 45 |
GSM687673 | Patient 424 control | 278.032 | 53 |
GSM687678 | Patient 425 control | 219.399 | 49 |
GSM687683 | Patient 427 control | 330.191 | 55 |
GSM687688 | Patient 428 control | 212.965 | 50 |
GSM687695 | Patient 441 control | 535.732 | 63 |
GSM687699 | Patient 443 control | 290.346 | 53 |
GSM687704 | Patient 444 control | 305.263 | 56 |
GSM687707 | Patient 448 control | 315.893 | 55 |
GSM687712 | Patient 449 control | 249.081 | 52 |
GSM687719 | Patient 450 control | 364.699 | 57 |
GSM687724 | Patient 451 control | 338.19 | 57 |
GSM687728 | Patient 452 control | 316.908 | 56 |
GSM687646 | Patient 401 treated 24h | 285.979 | 54 |
GSM687649 | Patient 402 treated 24h | 166.893 | 46 |
GSM687665 | Patient 411 treated 24h | 339.44 | 56 |
GSM687651 | Patient 402 treated 4 weeks | 262.642 | 52 |
GSM687667 | Patient 411 treated 4 weeks | 145.328 | 41 |
GSM687670 | Patient 422 treated 24h | 196.009 | 46 |
GSM687671 | Patient 422 treated 4 weeks | 197.408 | 49 |
GSM687654 | Patient 403 treated 24h | 248.42 | 54 |
GSM687675 | Patient 424 treated 24h | 274.371 | 52 |
GSM687685 | Patient 427 treated 24h | 189.596 | 47 |
GSM687656 | Patient 403 treated 4 weeks | 244.082 | 54 |
GSM687677 | Patient 424 treated 4 weeks | 267.366 | 54 |
GSM687687 | Patient 427 treated 4 weeks | 208.031 | 50 |
GSM687692 | Patient 428 treated 4h | 235.998 | 51 |
GSM687716 | Patient 449 treated 4h | 202.639 | 50 |
GSM687722 | Patient 450 treated 4h | 337.517 | 56 |
GSM687680 | Patient 425 treated 24h | 256.59 | 53 |
GSM687690 | Patient 428 treated 24h | 226.146 | 52 |
GSM687700 | Patient 443 treated 24h | 414.472 | 57 |
GSM687705 | Patient 444 treated 24h | 311.743 | 57 |
GSM687714 | Patient 449 treated 24h | 195.552 | 49 |
GSM687721 | Patient 450 treated 24h | 295.777 | 52 |
GSM687682 | Patient 425 treated 4 weeks | 192.227 | 49 |
GSM687694 | Patient 428 treated 4 weeks | 283.229 | 55 |
GSM687702 | Patient 443 treated 4 weeks | 384.428 | 58 |
GSM687718 | Patient 449 treated 4 weeks | 402.592 | 61 |
GSM687723 | Patient 450 treated 4 weeks | 305.945 | 55 |
GSM687661 | Patient 404 treated 4h | 271.376 | 53 |
GSM687710 | Patient 448 treated 4h | 288.151 | 55 |
GSM687726 | Patient 451 treated 4h | 239.12 | 49 |
GSM687730 | Patient 452 treated 4h | 1016.81 | 74 |
GSM687660 | Patient 404 treated 24h | 414.915 | 60 |
GSM687697 | Patient 441 treated 24h | 423.921 | 59 |
GSM687709 | Patient 448 treated 24h | 256.832 | 52 |
GSM687725 | Patient 451 treated 24h | 213.463 | 46 |
GSM687729 | Patient 452 treated 24h | 350.855 | 56 |
GSM687727 | Patient 451 treated 4 weeks | 268.701 | 52 |
GSM687731 | Patient 452 treated 4 weeks | 260.173 | 51 |